June 3, 2011 (London, United Kingdom) — Injectable collagenase significantly improved range of motion and degree of contracture in patients with Dupuytren's contracture, compared with placebo, in a ...

February 23, 2011 (San Diego, California) — Collagenase injections are associated with overall satisfactory rates of recontracture in patients with Dupuytren's disease of the hand, according to ...

Please provide your email address to receive an email when new articles are posted on . Injectable collagenase clostridium histolyticum has revolutionized treatment of Dupuytren’s contracture as the ...

All patients had Dupuytren's contracture of the MP joint between 20 and 100 degrees or of the PIP joint between 20 and 80 degrees in at least one digit (not the thumb). In CORD II, there were 45 ...

BERLIN — A prospective study of patients with Dupuytren’s contracture whose cords were treated with a collagenase clostridium histolyticum medication approved for use in Europe showed an overall 35% ...

Common activities for patients with Dupuytren's such as those at the workplace (eg, manual labor, wearing gloves) or at home (eg, washing, dressing) can be signicantly affected, posing a threat to ...

Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture XIAFLEX Also Meets ...

Auxilium Pharmaceuticals announced positive top-line data from its open-label phase 3b trial evaluating Xiaflex (collagenase clostridium histolyticum) for the treatment of adult Dupuytren’s ...

Because of the increased risk of complications and potential for recurrence associated with invasive surgical techniques, there has been renewed interest in simple fasciotomy to treat flexion ...